Aqr Capital Management LLC Alx Oncology Holdings Inc Transaction History
Aqr Capital Management LLC
- $151 Billion
- Q3 2025
A detailed history of Aqr Capital Management LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 10,793 shares of ALXO stock, worth $13,815. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,793
Previous 45,583
76.32%
Holding current value
$13,815
Previous $19,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ALXO
# of Institutions
69Shares Held
30.3MCall Options Held
173KPut Options Held
0-
Ven Bio Partners LLC San Francisco, CA9.7MShares$12.4 Million12.08% of portfolio
-
Redmile Group, LLC San Francisco, CA3.33MShares$4.27 Million0.67% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$3.44 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.62MShares$3.36 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA2.54MShares$3.25 Million2.19% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $52.2M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...